Browse by Day Archive
Lilly's experimental drug cuts weight by 21% in diabetes trial
09/29/2026 4:08pm
Eli Lilly said on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.
Lundbeck expresses interest in buying Xeris, Bloomberg News reports
09/29/2026 11:44am
Danish drugmaker H Lundbeck A/S has expressed interest in acquiring Chicago-based Xeris Biopharma, Bloomberg News reported on Tuesday, citing people familiar with the matter.
Utah sled hockey program reaches championship in 3rd year
09/29/2026 8:48am
What started as a new adaptive sports program in Utah three years ago already reached a championship game as the Utah Mammoth's sled hockey team's annual tournament this weekend.
US CDC confirms two measles-related deaths in 2026
09/29/2026 6:41am
The US Centers for Disease Control and Prevention on Tuesday confirmed a second measles-related death in the country this year, as cases continue to rise across the United States.
UniQure plunges as Huntington's trial data disappoints investors
09/29/2026 5:36am
UniQure said its gene therapy for Huntington's disease fell short of the goal of slowing disease progression significantly after four years, sending its US-listed shares plummeting 40% on Tuesday.
Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro
09/29/2026 5:12am
Novo Nordisk said on Tuesday a real-world study found that adults with type 2 diabetes who took an escalated dose of its diabetes drug, Ozempic, had a lower risk of major cardiovascular events compared to those who switched to Eli Lilly's Mounjaro.
Lilly touts Foundayo advantage over Novo's Ozempic pill in diabetes analysis
09/29/2026 4:47am
Eli Lilly said its oral obesity drug, Foundayo, offers greater weight loss and better blood sugar control than a higher dose of Novo Nordisk's Ozempic pill in adults with type 2 diabetes, citing data from existing studies.
